This clinical study is evaluating a new antibody treatment for Atherosclerotic Cardiovascular Disease), a condition that causes plaque build-up within the heart’s arteries. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.
Be 18 to 55 years old
Both males or females